J&J Strikes $230M Opioid Deal With NY AG, Exits Trial

By Emily Field (June 26, 2021, 1:25 PM EDT) -- Johnson & Johnson said Saturday that it had reached a $230 million deal with New York state and two Long Island counties to end their claims that the company's opioid marketing stoked the addiction epidemic, exiting the nation's first jury trial over the crisis, which will start Tuesday....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!